approval
saveIBANDRONATE SODIUM — FDA approval
community read0 votes
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 248d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 248d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 248d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 248d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 248d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 248d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 248d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 248d ago
same company · ±60 days · 6
- approvaltopiramate ER: TOPIRAMATE — FDA approvalJan 10, 2022
- approvaltopiramate ER: TOPIRAMATE — FDA approvalJan 10, 2022
- approvaltopiramate ER: TOPIRAMATE — FDA approvalJan 10, 2022
- approvaltopiramate ER: TOPIRAMATE — FDA approvalJan 10, 2022
- approvaltopiramate ER: TOPIRAMATE — FDA approvalJan 10, 2022
- approvaltopiramate ER: TOPIRAMATE — FDA approvalJan 10, 2022
comments(0)
5-min edit window · permanent after that